Venetoclax combined with rituximab in the treatment of ibrutinib-resistant patient with chronic lymphocytic leukemia: a case report and literature reviews.
10.3760/cma.j.issn.0253-2727.2019.08.018
- Author:
Chen Jing YE
1
;
Wen Bin XU
;
Qing YU
;
Chao WU
;
Lei HUANG
;
Jun Min LI
;
Hua YAN
Author Information
1. Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200025, China.
- Publication Type:Review
- MeSH:
Adenine/analogs & derivatives*;
Bridged Bicyclo Compounds, Heterocyclic;
Humans;
Leukemia, Lymphocytic, Chronic, B-Cell/drug therapy*;
Piperidines;
Pyrazoles/therapeutic use*;
Pyrimidines/therapeutic use*;
Rituximab/therapeutic use*;
Sulfonamides
- From:
Chinese Journal of Hematology
2019;40(8):700-702
- CountryChina
- Language:Chinese
